Laura Fletcher

Title: Laura Fletcher: Innovator in Cancer Biomarkers

Introduction

Laura Fletcher is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on cancer biomarkers. Her dedication to improving cancer diagnosis and treatment has led to the development of valuable methodologies that can aid in monitoring and diagnosing cancer.

Latest Patents

Laura Fletcher holds a patent for the invention titled "CCL22 and CCL17 cancer biomarkers." This invention provides methods for obtaining information relevant to monitoring and diagnosing cancer. Specifically, it focuses on monitoring the progression or development of cancer, assessing the response of cancer to treatment, diagnosing cancer, making cancer prognoses, predicting the likelihood of a cancer responding to treatment, and stratifying subjects with cancer. The methods involve determining the ratio of circulating CCL17 to circulating CCL22 in a sample from a subject. This patent represents a significant advancement in cancer research and has the potential to improve patient outcomes.

Career Highlights

Laura Fletcher is associated with Cancer Research Technology Limited, where she continues to work on innovative solutions in cancer research. Her expertise and commitment to the field have positioned her as a key figure in the development of cancer diagnostics.

Collaborations

Laura has collaborated with notable colleagues, including Frances Rosemary Balkwill and Chiara Berlato. These collaborations have further enhanced her research and contributed to the advancement of cancer biomarker studies.

Conclusion

Laura Fletcher's work in cancer biomarkers exemplifies the impact of innovation in medical research. Her contributions are paving the way for improved cancer diagnosis and treatment methodologies.